|  |   | 
		| (2 intermediate revisions not shown.) | 
| Line 1: | Line 1: | 
|  | + |  | 
|  | ==Crystal structure of FabI-NAD complex from Candidatus Liberibacter asiaticus== |  | ==Crystal structure of FabI-NAD complex from Candidatus Liberibacter asiaticus== | 
| - | <StructureSection load='4nk5' size='340' side='right' caption='[[4nk5]], [[Resolution|resolution]] 2.70Å' scene=''> | + | <StructureSection load='4nk5' size='340' side='right'caption='[[4nk5]], [[Resolution|resolution]] 2.70Å' scene=''> | 
|  | == Structural highlights == |  | == Structural highlights == | 
| - | <table><tr><td colspan='2'>[[4nk5]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/"candidatus_liberobacter_asiaticum"_jagoueix_et_al._1994 "candidatus liberobacter asiaticum" jagoueix et al. 1994]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4NK5 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4NK5 FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[4nk5]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Candidatus_Liberibacter_asiaticus Candidatus Liberibacter asiaticus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4NK5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4NK5 FirstGlance]. <br> | 
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAD:NICOTINAMIDE-ADENINE-DINUCLEOTIDE'>NAD</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.7Å</td></tr> | 
| - | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4nk4|4nk4]]</td></tr>
 | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NAD:NICOTINAMIDE-ADENINE-DINUCLEOTIDE'>NAD</scene></td></tr> | 
| - | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">WSI_01645 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=34021 "Candidatus Liberobacter asiaticum"Jagoueix et al. 1994])</td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4nk5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4nk5 OCA], [https://pdbe.org/4nk5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4nk5 RCSB], [https://www.ebi.ac.uk/pdbsum/4nk5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4nk5 ProSAT]</span></td></tr> | 
| - | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Enoyl-[acyl-carrier-protein]_reductase_(NADH) Enoyl-[acyl-carrier-protein] reductase (NADH)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.1.9 1.3.1.9] </span></td></tr>
 | + |  | 
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4nk5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4nk5 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4nk5 RCSB], [http://www.ebi.ac.uk/pdbsum/4nk5 PDBsum]</span></td></tr> | + |  | 
|  | </table> |  | </table> | 
|  | <div style="background-color:#fffaf0;"> |  | <div style="background-color:#fffaf0;"> | 
| Line 17: | Line 16: | 
|  | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> |  | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | 
|  | </div> |  | </div> | 
|  | + | <div class="pdbe-citations 4nk5" style="background-color:#fffaf0;"></div> | 
|  |  |  |  | 
|  | ==See Also== |  | ==See Also== | 
| - | *[[Enoyl-Acyl-Carrier Protein Reductase|Enoyl-Acyl-Carrier Protein Reductase]] | + | *[[Enoyl-Acyl-Carrier Protein Reductase 3D structures|Enoyl-Acyl-Carrier Protein Reductase 3D structures]] | 
|  | == References == |  | == References == | 
|  | <references/> |  | <references/> | 
|  | __TOC__ |  | __TOC__ | 
|  | </StructureSection> |  | </StructureSection> | 
| - | [[Category: Candidatus liberobacter asiaticum jagoueix et al. 1994]] | + | [[Category: Candidatus Liberibacter asiaticus]] | 
| - | [[Category: Dong, Y H]] | + | [[Category: Large Structures]] | 
| - | [[Category: Gao, Z Q]] | + | [[Category: Dong YH]] | 
| - | [[Category: Jiang, L]] | + | [[Category: Gao ZQ]] | 
| - | [[Category: Enoyl-acp reductase i]] | + | [[Category: Jiang L]] | 
| - | [[Category: Oxidoreductase]]
 | + |  | 
|  |   Structural highlights 
  Publication Abstract from PubMed Huanglongbing (HLB) is a destructive citrus disease. The leading cause of HLB is Candidatus Liberibacter asiaticus. Fatty acid biosynthesis(FAS-II)is essential for bacterial viability and has been validated as a target for the discovery of novel antibacterials agents. Enoyl-acyl carrier protein reductase (also called ENR or FabI and a product of the fabI gene) is an enzyme required in a critical step of bacterial fatty acid biosynthesis and has attracted attention as a target of novel antimicrobial agents. We determined the crystal structures of FabI from Ca. L. asiaticus in its apo-form as well as in complex with b-nicotinamide adenine dinucleotide (NAD) at 1.7 and 2.7 A resolutions, respectively, to facilitate the design and screening of small molecule inhibitors of FabI. The monomeric ClFabI is highly similar to other known FabI structures as expected, however, Unlike the typical tetramer, ClFabI exists as hexamer in crystal whereas as dimer in solution, on the other hand, the substrate binding loop which always disordered in apo form, FabI structures is ordered in apo ClFabI. Interestingly, the structure of ClFabI undergoes remarkable conformational change in the substrate-binding loop in the presence of NAD. We conclude that the signature sequence motif of FabI can be considered as Gly-(Xaa)5 -Ser-(Xaa)n-Val-Tyr-(Xaa)6 -Lys-(Xaa)n-Thr instead of Tyr-(Xaa)6 -Lys. We have further identified isoniazid as a competitive inhibitor with NADH.
 Crystal structures and kinetic properties of enoyl-acyl carrier protein reductase I from Candidatus Liberibacter asiaticus.,Jiang L, Gao Z, Li Y, Wang S, Dong Y Protein Sci. 2014 Jan 9. doi: 10.1002/pro.2418. PMID:24407918[1]
 From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
  See Also  References ↑ Jiang L, Gao Z, Li Y, Wang S, Dong Y. Crystal structures and kinetic properties of enoyl-acyl carrier protein reductase I from Candidatus Liberibacter asiaticus. Protein Sci. 2014 Jan 9. doi: 10.1002/pro.2418. PMID:24407918 doi:http://dx.doi.org/10.1002/pro.2418
 
 |